difference between glp and glp 1 The dual glucose-dependent insulinotropic polypeptide (GIP) glucagon-like peptide-1 (GLP-1) receptor agonist tirzepatide: a novel cardiometabolic therapeutic prospect | Cardiovascular Diabetology GLP1 Receptor Agonists vs SGLT2-I

May be given into a vein by IV May be given as a tablet by mouth May be given as a liquid by mouth Diarrhea Nausea Vomiting Upset stomach Abdominal (belly) pain Body odor Chest pain High blood pressure Swelling of the face, feet, or legs Skin irritation Changes in body weight Loss of appetite Change in taste Dark colored stools Headache Dizziness Vision changes Cough or runny nose Fever Allergic reaction Call your care team right away if your child has symptoms of an allergic reaction

doi: 10.1056/NEJMoa1515920 71 XuW

Care Companion J

Patients can reduce the likelihood of experiencing nausea by starting with a lower dose of the medication and gradually increasing the dose over time

$349 Glutathione Boost Seeking a holistic solution to boost your overall well-being & enhance your health

Temporary bloating is not the same as weight gain